This review examines evidence from the history of variolation, data on mucosal infection collected in the last decades of smallpox transmission, aerosol measurements, animal models, reports of smallpox lung among healthcare workers, and the epidemiology of smallpox regarding the potential importance of fine particle aerosol mediated transmission.
This paper summarizes clinical syndromes and possible treatment options, for both developed and low-resource settings, and offer performance indicators and clinical metrics for case management.
This report provides recommendations issued by the US Centers for Disease Control and Prevention (CDC) for Q fever recognition, clinical and laboratory diagnosis, treatment, management, and reporting for health-care personnel and public health professionals. The guidelines address treatment of acute and chronic phases of Q fever illness in children, adults, and pregnant women, as well as management of occupational exposures.
This paper offers an analytical framework is used to assess the risks and benefits of such dual use research, and relevant components of biosecurity policy and the biodefense enterprise (including the acquisition of medical countermeasures) in the United States are discussed.
This toolkit helps you work with key stakeholders to develop methods for the dispensing of medical countermeasures (such as antibiotics, antivirals, vaccines, and supplies) during public health emergencies involving public health agencies, hospitals, long term care facilities, and pharmacies.
This document presents a set of recommended standards for mass antibiotic dispensing that focus on the “points of dispensing” (or PODs, locations where the members of the public would go to receive life-saving antibiotics or other medical countermeasures during a large-scale public health emergency). Specifically, the standards address (1) the number and location of PODs, (2) internal POD operations, (3) POD staffing, and (4) POD security.
Per a directive from the US Centers for Disease Control and Prevention (CDC) large metropolitan regions have been tasked with delivering medication to the public within 48 hours after notification of a biological emergency event. Dispense Assist supports public health agencies with accomplishing this mission by providing an online screening tool that allows users to generate vouchers for medication.
This document outlines key topics, relevant resources, and current promising practices state and local medical countermeasure (MCM) planners should consider when creating and implementing plans to transition emergency mass dispensing operations from the initial 10-day antibiotic distribution and dispensing effort to distributing and dispensing extended post-exposure prophylactic MCMs.
The salient features of mass patient disrobe and decontamination are presented in Volume 3, which aims to provide all Federal, State, Tribal and local first responders with a simple, readily accessible guide to critical aspects of the incident response processes.
This document provides an overview of the processes involved in mass patient disrobe and decontamination and the rationale that underpins each process. The document does not include supporting technical information or potential challenges. Volume 2 has particular application in the training and exercising of first responders and officials involved with domestic preparedness and emergency management.